Chemtrail Awareness

The world will not be destroyed by those who do evil, but by those who watch and do nothing - Albert Einstein
HomePortalRegisterLog in

Display results as :
Rechercher Advanced Search
Latest topics
June 2018
Similar topics

Share | 

 Angelina Jolie part of a clever corporate scheme

Go down 

Posts : 7988
Join date : 2012-05-29
Location : Manchester UK

PostSubject: Angelina Jolie part of a clever corporate scheme   Mon 20 May 2013, 17:33

EXPOSED: Angelina Jolie part of a clever corporate scheme to protect
billions in BRCA gene patents, influence Supreme Court decision

(NaturalNews) Angelina Jolie's announcement of undergoing a double
mastectomy (surgically removing both breasts) even though she had no
breast cancer is not the innocent, spontaneous, "heroic choice" that has
been portrayed in the mainstream media. Natural News has learned it all coincides with a well-timed for-profit corporate P.R. campaign
that has been planned for months and just happens to coincide with the
upcoming U.S. Supreme Court decision on the viability of the BRCA1

This is the investigation the mainstream media refuses to
touch. Here, I explain the corporate financial ties, investors,
mergers, human gene patents, lawsuits, medical fear mongering and the trillions
of dollars that are at stake here. If you pull back the curtain on this
one, you find far more than an innocent looking woman exercising a
"choice." This is about protecting trillions in profits through the
deployment of carefully-crafted public relations campaigns designed to
manipulate the public opinion of women.

The signs were all there
from the beginning of the scheme: Angelina Jolie's highly polished and
obviously corporate-written op-ed piece at the New York Times, the
carefully-crafted talking points invoking "choice" as a
politically-charged keyword, and the obvious coaching of even her
husband Brad Pitt who carefully describes the entire experience using
words like "stronger" and "pride" and "family."

But the smoking gun is the fact that Angelina Jolie's seemingly spontaneous announcement magically appeared on the cover of People Magazine this week -- a magazine that is usually finalized for publication three weeks
before it appears on newsstands. That cover, not surprisingly, uses the
same language found in the NYT op-ed piece: "HER BRAVE CHOICE" and
"This was the right thing to do." The flowery, pro-choice language is
not a coincidence.

What this proves is that Angelina's Jolie's announcement was a well-planned corporate P.R. campaign with carefully-crafted messages designed to influence public opinion. But what could Jolie be seeking to influence? about trillions of dollars in corporate profits?

Upcoming U.S. Supreme Court decision to rule on patent viability for BRCA1 gene

Angelina Jolie's announcement and all its carefully-crafted language had four notable immediate impacts:

It caused women everywhere to be terrified of breast cancer through the
publishing of false statistics that drove fear into the hearts of
anyone with breasts. (See below for explanation.)

2) It caused women to rush out and seek BRCA1 gene testing procedures. These tests just happen to be patented by a for-profit corporation
called "Myriad Genetics." Because of this patent, BRCA1 tests can cost
$3,000 - $4,000 each. The testing alone is a multi-billion-dollar
market, but only if the patent is upheld in an upcoming Supreme Court
decision (see below).

It caused the stock price of Myriad Genetics (MYGN) to skyrocket to a
52-week high. "Myriad's stock closed up 3% Tuesday, following the
publication of the New York Times op-ed," wrote

It drove public opinion to influence the upcoming U.S. Supreme Court
decision to rule in favor of corporate ownership of human genes (see
more below).

Women all over the world are being duped into supporting Angeline Jolie,
having no idea that what she's really doing is selling out women to the
for-profit cancer industry. But to fully understand what's happening,
you have to dig deeper...

Myriad Genetics sees stock price skyrocket thanks to Jolie, and Obamacare will funnel billions their way

Lake City-based Myriad Genetics (MYGN) holds the patent on the test
that determined the actress had an 87% chance of developing breast
cancer, as well as the genes themselves," wrote

And that's only the beginning. If the U.S. Supreme Court can be influenced to uphold Myriad's patent, it could mean a trillion-dollar industry
over just the next few years. Even more, Myriad Genetics is reportedly
"ripe for mergers" according to the financial press, because it's part
of the super-hot human genome industry.

"The world's largest
maker of DNA testing and analysis tools, Life Technologies Corp. said
that it is set to be acquired by Thermo Fisher Scientific for a record
$13.6 billion," writes
"A race that kicked into high gear more than 26 years ago is heating
up, with foreign governments and corporations joining the U.S. in
funding the quest to map all the human genomes. And even as the recent
flurry of mergers and acquisitions in the genomics space has spurred
returns, investors still have opportunities to profit from this
multibillion-dollar industry."

The higher Myriad's stock price
goes, the more profitable a merger becomes for its current owners. So
Jolie's P.R. stunt just happened to generate unknown millions of dollars
in value for the very people who claim a patent monopoly over the
breast cancer genes residing in the bodies of women. Coincidence?

Obamacare mandates taxpayers pay for BRCA gene testing: yet another government handout to wealthy corporations

here's what's even more crooked about all this: You know how Obama
likes to talk "free market" but actually engages in so-called "crony
capitalism" by handing out money to all his corporate buddies, Wall
Street insiders and deep-pocketed campaign donors? Part of Obamacare --
the "Affordable Care Act" -- mandates that taxpayers pay for BRCA1 genetic testing!

Genetics, in other words, stands to receive a full-scale windfall of
profits mandated by government and pushed into mainstream consciousness
through a campaign of "medical terror" fronted by Angelina Jolie and the
New York Times. Are you starting to see how this all fits together yet?

This is all one big coordinated corporate sellout of women,
and it's all being hidden by playing the "women's power" card and using
"choice" language to more easily manipulate women. Angelina Jolie,
remember, is a key spokesperson for the United Nations, an organization
already caught engaged in child sex slavery and drug running. Although Jolie obviously isn't engage in that sort of behavior, her job is to covertly influence American women into supporting a carefully-planned, plotted and executed corporate profit campaign that turns women's bodies into profits.

Here's why the Supreme Court decision puts trillions of dollars at stake...

Details on the upcoming Supreme Court decision

ACLU and the Public Patent Foundation filed a lawsuit in 2009,
challenging the corporate ownership of human genes. Anyone who believes
in women's rights, human rights, civil rights or even the right to eat
non-GMO foods should immediately agree that corporations should NOT be able to patent human genes and then use those patents to rake in billions of dollars in profits while stifling scientific research into those genes.

question to all women reading this: Do you believe a corporation in
Utah owns your body? If not, you should be opposed to corporate
ownership of human genes. It also means you should oppose Angelina
Jolie's P.R. campaign because although she's running a brilliant public
relations campaign, behind the scenes her actions are feeding
potentially trillions of dollars of profits directly into the for-profit
human gene patenting industry that denies human beings ownership over their own genetic code.

The ACLU explains the basics of its lawsuit against Myriad Genetics as follows:

May 12, 2009, the ACLU and the Public Patent Foundation (PUBPAT) filed a
lawsuit charging that patents on two human genes associated with breast
and ovarian cancer, BRCA1 and BRCA2, are unconstitutional and invalid.
On November 30, 2012, the Supreme Court agreed to hear argument on the
patentability of human genes. The ACLU argued the case before the U.S.
Supreme Court on April 15, 2013. We expect a decision this summer.

behalf of researchers, genetic counselors, women patients, cancer
survivors, breast cancer and women's health groups, and scientific
associations representing 150,000 geneticists, pathologists, and
laboratory professionals, we have argued that human genes cannot be
patented because they are classic products of nature. The suit charges
that the gene patents violate the First Amendment and stifle diagnostic testing and research that could lead to cures and that they limit women's options regarding their medical care.

that? If the Supreme Court rules against Myriad Genetics, it will cause
a multi-billion-dollar breast cancer genetic testing industry to
collapse virtually overnight. This means a huge loss for not just
Myriad, but also many other human gene corporations that wish to exploit
the human body -- including the bodies of women -- for monopolistic
profits. (All patents are government-granted monopolies.) Ultimately, trillions of dollars in corporate gene patents are at stake here.

Patenting human genes is huge business

Today, about 20 percent of your genes are already patented
by corporations and universities. As the ACLU explains, "A gene patent
holder has the right to prevent anyone from studying, testing or even
looking at a gene. As a result, scientific research and genetic testing
has been delayed, limited or even shut down due to concerns about gene

This means that when corporations own patents on human genes, it stifles scientific research
while granting that corporation a monopoly over the "intellectual
property" encoded in your own DNA! (How criminal is that? You decide...)

What this means is that if the Supreme Court rules against Myriad, it would set a precedent that would dismantle the entire human gene patenting industry, affecting trillions of dollars in future profits.

I believe, is the real reason behind Angelina Jolie's announcement. It
seems designed to invoke women's emotional reactions and create a
groundswell of support for corporate-owned genes, thereby handing these
corporations a Supreme Court precedent that will ensure trillions in
future profits. It's a for-profit PR stunt that tries to trick women
into supporting a corporate system of patents and monopolies that
claims, right now, to own portions of the bodies of every woman living

While most media outlets have no clue about the patent issues at stake here, the Detroit Free Press took notice, saying:

Hollywood star's decision to get tested for a breast cancer gene
mutation, undergo a double mastectomy and then write about it calls
attention to a case now pending before the court. The justices have just
weeks to decide if Myriad Genetics' patent on the two genes that can
identify an increased risk of breast and ovarian cancer is legal.
Critics complain that the company's monopoly leaves them as the sole
source of the $4,000 tests needed to determine each woman's risk."

Lying with statistics: Jolie's 87% risk exaggeration

There's more to this story than just the patents on BRCA1 and BRCA2 genes. Angelina Jolie is also using blatantly misleading statistics to terrify women into thinking their breasts might kill them.

the NYT op-ed piece, Jolie claims her doctor told her she has an "87%
risk" of developing breast cancer. But what she didn't tell you is that
this number doesn't apply to the entire population: it's actually old data
derived almost exclusively from families that were previously
documented to have very high risks of breast cancer to begin with.

A study published on the National Human Genome Research Institute website
and conducted by scientists from the National Institutes of Health
reveals that breast cancer risks associated with BRCA1 genes are significantly lower than what's being hyped up by Jolie and the mainstream media.

In fact, in a large room of 600 women, only ONE will likely have a BRCA mutation
in her genetic code. The actual incidence is 0.125 to 0.25 out of 100
women, or 1 in 400 to 1 in 800. I used 600 as the average of 400 and

And out of that 1 in 600 women who has the mutation, her risk of breast cancer is only 56 percent,
not 78 percent as claimed by Jolie. But 13 percent of women without the
BRCA mutation get breast cancer anyway, according to this scientific
research, so the increased risk is just 43 out of 100 women.

what we're really talking about here is 1 in 600 women having a BRCA
gene mutation, then less than half of those getting cancer because of
it. In other words, only about 1 in 1200 women will be affected by this.

thanks to people like Jolie and the fear-mongering mainstream media,
women all across the nation have been terrified into believing their
breasts might kill them and the best way to handle the problem is to cut
them off!

This, my friends, is the essence of doomsday fear
mongering. This issue affects less than one-tenth of one percent of
women but is being riled up into a nationwide fear campaign that just
happens to feed profits into the for-profit cancer diagnosis and
treatment industry, not to mention the monopolistic human gene patenting

That's the real story of what's happening here. Don't expect to read this in the New York Times.

Corporate media refuses to mention real prevention and treatment options

part of the breast cancer fear mongering and treatment scam now being
run across the mainstream media, nearly all media sources are
prohibiting any mention of holistic or natural options for treatment or

Sure, the media talks about "options," but all those
options just happen to lead back to the for-profit cancer industry. As
an example, read this story by ABC News, part of the lying mainstream media that misinforms women and pushes a corporate agenda:

you do test positive for BRCA, you have options, and you don't
necessarily have to go the Jolie route. Some women choose not to have
surgery. Instead, they increase cancer surveillance with imaging tests.
These include regular mammograms to test for breast cancer, and regular
pelvic sonograms and blood-tests to watch for ovarian cancer.

in this article does ABC News mention ways to suppress the BRCA1 gene
by, for example, eating raw cruciferous vegetables containing Indole-3-Carbinol (I3C), a potent anti-cancer nutrient that halts breast cancer in its tracks. Nowhere does ABC News mention vitamin D which prevents nearly 4 out of 5 cancers of all types, including breast cancer.

the "options" being pushed by mainstream media are nothing more than
mammograms, surgery, radiation and chemotherapy -- all owned and run by
the for-profit cancer industry that feeds on women and exploits their
bodies for profit.

Nor is their any discussion of the total scam of the "pink ribbons" cancer cure industry which is primarily focused on giving women cancer through "free mammograms." As any scientist or physicist already knows, mammograms cause cancer
because they emit ionizing radiation directly into the breast and heart
tissues. Get enough mammograms done and sooner or later they will
detect breast cancer because they caused it! To date, 1.3 million women have been harmed by mammography.

Angelina, for keeping the wool pulled over the eyes of women everywhere
while selling out to for-profit, monopolistic, corporate interests that
incessantly seek to exploit women for profit.

Back to top Go down
Angelina Jolie part of a clever corporate scheme
Back to top 
Page 1 of 1
 Similar topics
» Angelina Jolie
» Fantasy Group RP Part 3 Archived
» Obama to crack down on overseas tax loopholes
» Celebrity Schadenfreude
» The team is following another equally strong line of inquiry that she might now be dead

Permissions in this forum:You cannot reply to topics in this forum
Chemtrail Awareness :: News & Events Around The World-
Jump to: